Package 59676-280-90

Brand: edurant ped

Generic: rilpivirine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 59676-280-90
Digits Only 5967628090
Product NDC 59676-280
Product ID 59676-280_3d6d0fcc-0b62-b76b-e063-6294a90aea43
Description

9 BLISTER PACK in 1 CARTON (59676-280-90) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (59676-280-01)

Marketing

Marketing Status
Marketed Since 2024-03-15
Brand edurant ped
Generic rilpivirine hydrochloride
Sample Package No

Linked Drug Pages (1)

EDURANT, EDURANT PED ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3d6d0fcc-0b62-b76b-e063-6294a90aea43", "openfda": {"upc": ["0359676278016"], "unii": ["212WAX8KDD"], "rxcui": ["1102273", "1102277", "2678244", "2678248"], "spl_set_id": ["03880372-2c68-45c6-a53a-f420c49541d6"], "manufacturer_name": ["Janssen Products, LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "9 BLISTER PACK in 1 CARTON (59676-280-90)  / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (59676-280-01)", "package_ndc": "59676-280-90", "marketing_start_date": "20240315"}], "brand_name": "EDURANT PED", "product_id": "59676-280_3d6d0fcc-0b62-b76b-e063-6294a90aea43", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "59676-280", "generic_name": "rilpivirine hydrochloride", "labeler_name": "Janssen Products, LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EDURANT PED", "active_ingredients": [{"name": "RILPIVIRINE HYDROCHLORIDE", "strength": "2.5 mg/1"}], "application_number": "NDA219016", "marketing_category": "NDA", "marketing_start_date": "20240315", "listing_expiration_date": "20261231"}